This industry survey seeks to gain insight on the drug developer’s perspective on bioavailability enhancement technologies and the reasoning behind the use of certain technologies over others in preclinical and early-stage clinical development.

Please take a moment to share your thoughts and the first 50 qualified respondents will receive a $5 Amazon gift card.